Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Verhoef LM, van den Bemt BJ, van der Maas A, Vriezekolk JE, Hulscher ME, van den Hoogen FH, Jacobs WC, van Herwaarden N, den Broeder AA. Verhoef LM, et al. Among authors: van den bemt bj, van herwaarden n, van den hoogen fh, van der maas a, den broeder aa. Cochrane Database Syst Rev. 2019 May 24;5(5):CD010455. doi: 10.1002/14651858.CD010455.pub3. Cochrane Database Syst Rev. 2019. PMID: 31125448 Free PMC article.
InforMatrix: treatment of rheumatoid arthritis using biologicals.
van den Bemt BJ, van den Hoogen FH, Breedveld FC, van der Tempel H, Janknegt R. van den Bemt BJ, et al. Among authors: van den hoogen fh, van der tempel h. Expert Opin Pharmacother. 2006 Sep;7(13):1769-89. doi: 10.1517/14656566.7.13.1769. Expert Opin Pharmacother. 2006. PMID: 16925504 Review.
Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusion cycle: an open-label pharmacokinetic cohort study.
van den Bemt BJ, den Broeder AA, Wolbink GJ, Hekster YA, van Riel PL, Benraad B, van den Hoogen FH. van den Bemt BJ, et al. Among authors: van den hoogen fh, den broeder aa, van riel pl. BMC Musculoskelet Disord. 2011 Jan 13;12:12. doi: 10.1186/1471-2474-12-12. BMC Musculoskelet Disord. 2011. PMID: 21232150 Free PMC article. Clinical Trial.
Treatment outcomes of a Numeric Rating Scale (NRS)-guided pharmacological pain management strategy in symptomatic knee and hip osteoarthritis in daily clinical practice.
Snijders GF, van den Ende CH, van den Bemt BJ, van Riel PL, van den Hoogen FH, den Broeder AA; NOAC study group. Snijders GF, et al. Among authors: van den bemt bj, van den hoogen fh, van riel pl, den broeder aa, van den ende ch. Clin Exp Rheumatol. 2012 Mar-Apr;30(2):164-70. Epub 2012 Apr 13. Clin Exp Rheumatol. 2012. PMID: 22325619
Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study.
van der Maas A, Kievit W, van den Bemt BJ, van den Hoogen FH, van Riel PL, den Broeder AA. van der Maas A, et al. Among authors: van den bemt bj, van den hoogen fh, van riel pl, den broeder aa. Ann Rheum Dis. 2012 Nov;71(11):1849-54. doi: 10.1136/annrheumdis-2011-200945. Epub 2012 Apr 13. Ann Rheum Dis. 2012. PMID: 22504561
Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study.
van der Maas A, van den Bemt BJ, Wolbink G, van den Hoogen FH, van Riel PL, den Broeder AA. van der Maas A, et al. Among authors: van den bemt bj, van den hoogen fh, van riel pl, den broeder aa. BMC Musculoskelet Disord. 2012 Sep 24;13:184. doi: 10.1186/1471-2474-13-184. BMC Musculoskelet Disord. 2012. PMID: 23006627 Free PMC article.
213 results